Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

An update on a Phase 2 study of ASP1941 in participants with Type 2 diabetes mellitus, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP1941

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED